RxDoctor Payments Data

Keith Volk

Acute Care · Longmont, CONPI 1366923666

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,624 of the $5,254 with a category attached, or 69.0%. 13 manufacturers reported payments, led by Boston Scientific at 48.3% of the total. Reporting peaked in 2022 at $2,167 and has fallen 84.8% since, to $329 in 2025. Among acute care clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,254in general payments, 2019–2025

Across 73 payments — averaging $71.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Edwards Lifesciences$1K
  • Abbott$645
  • Medtronic$467
  • Abiomed$109
  • Bayer$109
  • plus $204 from 7 others

What the payments were for

  • Travel & lodging$1,62931%
  • Food & beverage$3,62469%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,254 in reported general payments places this provider in the 90th percentile of 239 acute care providers in Colorado.

See all acute care providers in Colorado

Medicare billing

Part B allowed, 2024
$36,501
Medicare patients
261
Services billed
414

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin37$52,136
EliquisApixaban16$15,900
Bumetanide51$2,132
Potassium Chloride86$2,056
Metoprolol Succinate137$1,987
Ezetimibe32$1,085
Rosuvastatin Calcium38$778
Furosemide109$688
Losartan Potassium76$687
Spironolactone63$648
ClopidogrelClopidogrel Bisulfate37$565
Diltiazem 24hr Er (Cd)Diltiazem Hcl14$497
Carvedilol57$491
Atorvastatin Calcium51$430
Amiodarone Hcl19$388

Paid to pharmacies, not to this prescriber.

Other acute care in Longmont

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →